Polyphenol-rich foods have shown promise in preliminary research as potential GLP-1 enhancers
Not intended for diagnosis or treatment of any medical condition
Retatrutide might work best in adults with obesity or metabolic conditions who have surplus visceral fat
Why Patient Behavior Is Reshaping the GLP-1 Landscape In the fast-shifting world of obesity treatment, patient behavior is proving to be a powerful force, one that can make or break the success of even the most promising therapies
Also, these medications should be used with caution in individuals with a history of pancreatitis or thyroid C-cell tumors due to a potential increased risk associated with these conditions
LY3437943, a Novel Triple Glucagon, GIP, and GLP-1 Receptor Agonist for Glycemic Control and Weight Loss: From Discovery to Clinical Proof of Concept